论文部分内容阅读
目的研究急性髓系白血病(AML)Hras/P21、抗凋亡基因(bcl2)、细胞凋亡与多药耐药基因(mdr1/Pgp)对疗效的影响,并证实流式细胞术(FCM)检测Pgp和逆转录多聚酶链反应(RTPCR)检测mdr1mRNA间的相关。方法用FCM检测85例初治AML患者的Hras/P21、bcl2、细胞凋亡和mdr1产物Pgp的表达;用RTPCR检测其中47例的mdr1/mRNA。结果P21+/Pgp+者完全缓解(CR)率明显低于P21-/Pgp-者(分别为58.1%和100%,P<0.025),高bcl2/Pgp+的CR率明显低于低bcl2/Pgp-者(分别为60%和96.3%,P<0.005)。Pgp+31例中29例mdr1mRNA阳性,Pgp-16例中仅2例mdr1mRNA阳性。结论Pgp+同时P21+、高bcl2者CR低,FCM检测Pgp和RTPCR检测mdr1mRNA相关性良好
Objective To investigate the effect of H ras/P21, anti-apoptosis gene (bcl 2), apoptosis and multidrug resistance gene (mdr 1/P gp) on acute myeloid leukemia (AML) and confirm the efficacy of Flow cytometry (FCM) was used to detect the relationship between Pgp and reverse transcriptase polymerase chain reaction (RTPCR) to detect mdr1 mRNA. Methods The expression of Hras/P21, bcl2, apoptosis and the expression of mdr1 product Pgp in 85 patients with newly diagnosed AML were detected by FCM. 47 cases of mdr1/mRNA were detected by RTPCR. Results The complete remission (CR) rate of P21+/Pgp+ was significantly lower than that of P21–/Pgp– (58.1% and 100%, P<0.025, respectively). High bcl2/Pgp+ The CR rate was significantly lower than those with low bcl-2/P-gp- (60% and 96.3%, respectively, P<0.005). Twenty-nine cases of Pgp+ were positive for mdr 1 mRNA, and only 2 cases of pgp-16 were positive for mdr1 mRNA. Conclusion P gp + P21 +, high bcl 2 were low CR, FCM detection of P gp and RT PCR detection of mdr 1 mRNA correlation